» Authors » Mark Stewart

Mark Stewart

Explore the profile of Mark Stewart including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 116
Citations 1211
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hadd A, Silvestro A, McKelvey B, Baden J, Bormann Chung C, Brown B, et al.
Clin Transl Sci . 2025 Mar; 18(3):e70185. PMID: 40070025
The use of a liquid biopsy to assess molecular residual disease (MRD) of solid tumors holds significant promise for improving outcomes for patients with cancer. Liquid biopsies are a minimally...
2.
Miklavcic D, Verma A, Krahn P, Stublar J, Kos B, Escartin T, et al.
Sci Rep . 2024 Dec; 14(1):32063. PMID: 39738639
Pulsed Field Ablation (PFA) is a new ablation method being rapidly adopted for treatment of atrial fibrillation, which shows advantages in safety and efficiency over radiofrequency and cryo-ablation. In this...
3.
Dombeck C, Swezey T, Kehoe L, Kinchen K, Roe M, Stewart M, et al.
J Clin Transl Sci . 2024 Dec; 8(1):202. PMID: 39655006
Introduction: Researchers and policymakers recognize that leveraging data routinely collected in clinical practice can support improved research and patient care. Embedding elements of clinical trials, such as patient identification and...
4.
Cooper L, Ansari M, Capshaw G, Galazyuk A, Lauer A, Moss C, et al.
Ann N Y Acad Sci . 2024 Oct; 1541(1):10-23. PMID: 39365995
Bats (order Chiroptera) are emerging as instructive animal models for aging studies. Unlike some common laboratory species, they meet a central criterion for aging studies: they live for a long...
5.
Merola D, Campbell U, Lenis D, Schneeweiss S, Wang S, Madsen A, et al.
JAMA Netw Open . 2024 Sep; 7(9):e2436535. PMID: 39348118
Importance: The conditions required for health record data sources to accurately assess treatment effectiveness remain unclear. Emulation of randomized clinical trials (RCTs) with health record data and subsequent calibration of...
6.
Clarke C, Mitchell B, Putcha G, Alme E, Bach P, Beer J, et al.
Clin Transl Sci . 2024 Aug; 17(9):e70016. PMID: 39206679
In the United States, 2.0 million new cancer cases and around 600,000 cancer deaths are estimated to occur in 2024. Early detection gives cancer patients the best chance for treatment...
7.
Lockwood C, Merker J, Bain E, Compton C, Grossman R, Johann D, et al.
Clin Pharmacol Ther . 2024 Aug; 117(1):28-33. PMID: 39164947
BLOODPAC is a public-private consortium that develops best practices, coordinates clinical and translational research, and manages the BLOODPAC Data Commons to broadly support the liquid biopsy community and accelerate regulatory...
8.
Legge E, Stewart M, Contreras Chavez L, Zhang H, Tsikritsis D, Belsey N, et al.
J Pharm Sci . 2024 May; 113(8):2464-2474. PMID: 38777176
The formulation of paediatric medicines faces significant challenges to meet the requirements for safe and accurate administration, while maintaining a suitable taste. Multiparticulate formulations have a strong potential to address...
9.
Chandrakumaran J, Stewart M, Srivastava P
PLoS One . 2023 Oct; 18(10):e0292395. PMID: 37788286
To ensure uncertainty in match outcomes, professional sporting leagues have used various competitive balance policies, including player salary caps, revenue sharing among teams and player drafts. The Australian Football League...
10.
Unger J, Stires H, Levit L, Stewart M, McKelvey B, Canin B, et al.
JCO Oncol Pract . 2023 Aug; 19(10):907-916. PMID: 37643386
Purpose: The onset of the COVID-19 pandemic created major disruptions in the conduct of cancer clinical trials. In response, regulators and sponsors allowed modifications to traditional trial processes to enable...